According to Abiomed's latest financial reports the company's current earnings (TTM) are $0.34 B. In 2021 the company made an earning of $0.18 B a decrease over its 2020 earnings that were of $0.25 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $0.34 B | 80.23% |
2021 | $0.18 B | -25.49% |
2020 | $0.25 B | -19.62% |
2019 | $0.31 B | 48.14% |
2018 | $0.21 B | 51% |
2017 | $0.14 B | 71.85% |
2016 | $82.21 M | 41.79% |
2015 | $57.98 M | 187.69% |
2014 | $20.15 M | 126.26% |
2013 | $8.9 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $1.98 B | 481.83% | ๐บ๐ธ USA |
Teleflex TFX | $0.51 B | 52.15% | ๐บ๐ธ USA |
AtriCure ATRC | -$22.93 M | -106.72% | ๐บ๐ธ USA |